Workflow
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates
LQDALiquidia Corp(LQDA) ZACKS·2025-03-19 12:45

Group 1 - Liquidia Technologies, Inc. reported a quarterly loss of 0.46pershare,whichwasworsethantheZacksConsensusEstimateofalossof0.46 per share, which was worse than the Zacks Consensus Estimate of a loss of 0.38, and compared to a loss of 0.42pershareayearago,indicatinganearningssurpriseof−21.050.42 per share a year ago, indicating an earnings surprise of -21.05% [1] - The company posted revenues of 2.92 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 43.11%, and this represents a decline from year-ago revenues of 4.53million[2]−Overthelastfourquarters,LiquidiaTechnologieshasnotsurpassedconsensusEPSestimatesandhastoppedconsensusrevenueestimatesonlyonce[2]Group2−LiquidiaTechnologiesshareshaveincreasedbyapproximately25.34.53 million [2] - Over the last four quarters, Liquidia Technologies has not surpassed consensus EPS estimates and has topped consensus revenue estimates only once [2] Group 2 - Liquidia Technologies shares have increased by approximately 25.3% since the beginning of the year, contrasting with a decline of -4.5% in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -0.34 on revenues of 4.14million,andforthecurrentfiscalyear,itis−4.14 million, and for the current fiscal year, it is -1.14 on revenues of $47.04 million [7] - The Medical - Biomedical and Genetics industry, to which Liquidia Technologies belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]